Your session is about to expire
← Back to Search
Spanish-Language Hearing Loss Toolkit for Hearing Loss
N/A
Recruiting
Led By Michelle Arnold, Au.D., Ph.D.
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants will include community-dwelling, Spanish-speaking (monolingual or bilingual) adults over age 50 who self-identify as Hispanic/Latino
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed 4-6 weeks post baseline assessment
Awards & highlights
Study Summary
This trial is testing whether Spanish-language hearing education materials help adults better understand their hearing loss and how to manage it.
Who is the study for?
This trial is for Spanish-speaking adults over 50 who identify as Hispanic/Latino, have significant hearing loss or difficulty hearing. To join, they must experience more than a mild level of hearing loss across various pitches or report substantial hearing challenges.Check my eligibility
What is being tested?
The study is testing educational materials in Spanish designed to help participants understand and manage their hearing loss better. It compares the effectiveness of a new toolkit against existing ASHA audiology handouts.See study design
What are the potential side effects?
Since this trial involves educational materials rather than medical treatments, there are no direct physical side effects expected from participating in this study.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 50, Hispanic/Latino, and speak Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed 4-6 weeks post baseline assessment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed 4-6 weeks post baseline assessment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Self-Efficacy for Chronic Health Condition Management (generic )
Hearing impairment
Secondary outcome measures
Hearing Loss Knowledge, Attitudes, and Behaviors
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental GroupExperimental Treatment1 Intervention
This group will receive the Spanish-Language Hearing Loss Toolkit materials.
Group II: Active Control GroupActive Control1 Intervention
This group will receive standard of care Spanish language information from the American Speech-Language-Hearing Association (ASHA) Audiology Series
Find a Location
Who is running the clinical trial?
University of South FloridaLead Sponsor
404 Previous Clinical Trials
185,129 Total Patients Enrolled
7 Trials studying Hearing Loss
1,492 Patients Enrolled for Hearing Loss
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
327 Previous Clinical Trials
178,206 Total Patients Enrolled
54 Trials studying Hearing Loss
19,840 Patients Enrolled for Hearing Loss
Michelle Arnold, Au.D., Ph.D.Principal InvestigatorUniversity of South Florida
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 50, Hispanic/Latino, and speak Spanish.You have trouble hearing and it is confirmed by a hearing test or by reporting significant difficulty with hearing.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental Group
- Group 2: Active Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open slots for enrolment in this medical experiment?
"That is correct. According to clinicaltrials.gov, this study launched on April 22nd 2021 and is still actively recruiting 110 participants from one location as of the last update made in April 6th 2022."
Answered by AI
What is the upper boundary of participants that can join this experiment?
"Affirmative. According to clinicaltrials.gov, this medical trial is actively recruiting patients and was posted on April 22nd 2021. Most recently updated on April 6th 2022, the study hopes to enrol 110 participants from a single location."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger